Richard Burr: “I ask my colleagues for their support on S. 669 so that we can right what I think is a tremendous wrong.”

Ms. Kotagal's refusal to continue these common-sense measures speaks volumes of her lack of commitment to due process and transparency.

I was surprised and frustrated to hear that these funds were overwhelmingly repurposed from within ASPR, including the stockpile.

It is time that we hold the FDA accountable.

I will continue to ask you for a plan until we get one, and I will continue to be a roadblock for those who believe that we can blindly just appropriate emergency money.